The pro-inflammatory cytokines tumor necrosis factor (TNF), interleukin-1 (IL-1) and interleukin-6 (IL-6) are key players of the innate and adaptive immunity. Their activity needs to be tightly controlled to allow the initiation of an appropriate immune response as defense mechanism against pathogens or tissue injury. Excessive or sustained signaling of either of these cytokines leads to severe diseases, including rheumatoid arthritis, inflammatory bowel diseases (Crohn's disease, ulcerative colitis), steatohepatitis, periodic fevers and even cancer. Studies carried out in the last 30 years have emphasized that an elaborate control system for each of these cytokines exists. Here, we summarize what is currently known about the involvement of receptor endocytosis in the regulation of these pro-inflammatory cytokines' signaling cascades. Particularly in the last few years it was shown that this cellular process is far more than a mere feedback mechanism to clear cytokines from the circulation and to shut off their signal transduction.
Introduction
TNF, IL-1 and IL-6 represent master regulators of the inflammatory response, which are involved in the coordination of the body's response to pathogen-and danger-associated molecular patterns (PAMP, DAMP). They signal via distinct cell surface receptor complexes which belong to the family of cytokine receptors with associated kinases, but which are devoid of intrinsic enzymatic activity. Despite this common feature, their receptors differ substantially. IL-6 signals via a cytokine receptor containing a conserved membrane-proximal proline-rich region denominated box 1 region and required for the recruitment of Janus family tyrosine kinases (Heinrich et al., 2003) . IL-1, on the other hand, utilizes a receptor complex containing the conserved toll-like/IL-1 receptor (TIR) domain to which adapter proteins like MyD88 (myeloid differentiation factor 88) recruit serine/threonine kinases of the IL-1 receptor associated kinase (IRAK) family (O'Neill, 2008) . TNF, in a trimeric fashion, oligomerizes either receptors containing a so-called death domain (TNF receptor 1, TNFR1) or devoid of this domain (TNF receptor 2, TNFR2). Despite the lack of any intracellular homology, both TNFRs recruit TNFR associated factors (TRAFs) and serine/threonine kinases of the receptor-interacting protein family (RIP) (Aggarwal, 2003; Wajant et al., 2003) . Even though their receptor complexes and activated signaling cascades are divergent, these cytokines share a number of common crucial regulatory mechanisms. These include the induction of feedback inhibitors, the activation of phosphatases and receptor endocytosis. It should be pointed out that each of these mechanisms is of fundamental importance to control the action of each cytokine. First and foremost the immediate early induction of feedback inhibitors like the SOCS (suppressor of cytokine signaling) proteins in case of IL-6 and -among others -IκB (inhibitor of nuclear factor-κB) in case of IL-1 or TNF needs to be named. Their importance for the regulation of cytokine responses has been reviewed by other groups (Heinrich et al., 2003; Ruland, 2011; Babon et al., 2014; Wallach, 2016) and is not topic of this overview.
In contrast to the substantial information available about molecular mechanisms and the physiological relevance of G protein coupled receptor and growth factor receptor endocytosis, our current knowledge regarding cytokine receptor endocytosis is rather limited. Endocytosis of cell surface receptors is mediated by clathrin-dependent (McMahon and Boucrot, 2011) or clathrinindependent pathways. With respect to cytokine receptor endocytosis the most relevant clathrin-independent pathways appear to be the caveolae-mediated endocytosis, the clathrin-independent carrier/GPI-AP-enriched early endosomal compartment (CLIC/GEEC) pathway (Howes et al., 2010) and the recently described fast endophilinmediated endocytosis (FEME) (Boucrot et al., 2015) . As far as currently understood, endocytosis of cytokine receptors can occur constitutively, like for many nutrient receptors, or signaling dependent. Of note, endocytosis of receptors does not necessarily result in termination of signaling, it might even be a prerequisite for the activation of specific signaling pathways. The following chapters summarize the current knowledge about the molecular mechanisms and relevance of endocytosis for IL-6-, IL-1-and TNF-mediated signal transduction.
Interleukin-6 Receptors and signaling
In order to signal, IL-6 requires two receptors, the IL-6 receptor alpha (IL-6Rα, CD126) (Yamasaki et al., 1988) and the signal transducing receptor subunit glycoprotein 130 (gp130, CD130, IL6ST) (Hibi et al., 1990) . IL-6 binds with relatively low affinity to the IL-6Rα (K d = 300-500 pm), while the association of IL-6 and IL-6Rα with gp130 results in formation of the high-affinity complex (K d = 15-60 pm). Interestingly, coexpression of IL-6Rα and gp130 in COS-7 cells did not result in equivalently high affinities for IL-6 as observed, e.g. in the hepatoma cell line HepG2, where affinities were one order of magnitude higher (Dittrich et al., 1994) . This phenomenon remains up to date unexplained.
The principal signaling pathways activated by IL-6 have been reviewed in detail before (Heinrich et al., 2003) and are therefore summarized only briefly here. Depending on the concentration of the cytokine, the cell type and the co-stimulatory milieu, IL-6 requires the gp130-associated Janus kinases (JAK1, JAK2 and Tyk2) to activate transcription factors of the STAT family (STAT3, STAT1), the mitogen-activated protein kinases (MAPK) ERK1 and ERK2, and the PI3K pathway. A celltype dependent activation of STAT5 and the AMP-regulated kinase has also been described (Kelly et al., 2009; Tormo et al., 2012) . So far, all signals initiated by IL-6 are transduced from the gp130 receptor subunit. The IL-6Rα contains an 82 amino acid (aa) long intracellular region, which is completely dispensable for signal transduction (Taga et al., 1989) . Studies on the physiological role of this domain identified a membrane-proximal tyrosinebased sequence (Y408SLG) and a di-leucine-like motif (L427, I428) as crucial signals to target the expression of IL-6Rα to the basolateral membrane in polarized cells (Martens et al., 2000) . The basolateral targeting motif in gp130 was found to overlap with the di-leucine sequence (L786, L787) identified to be important for gp130 endocytosis as discussed below Doumanov et al., 2006) .
Ligand-dependent endocytosis of the IL-6 receptor complex
Within minutes, intravenously injected radiolabeled 125I-rhIL-6 is cleared from the circulation. The main organ of accumulation and IL-6 inactivation is the liver. Indeed, IL-6 is rapidly internalized and degraded by hepatocytes (Castell et al., 1988; Sonne et al., 1990; Zohlnhofer et al., 1992) . Of note, most of our current knowledge regarding the internalization process of IL-6 and the IL-6 receptor complex is derived from experiments performed in transiently or stably transfected cell lines overexpressing wildtype or mutant versions of IL-6Rα and gp130. So far, these experiments suggested that endocytosis of gp130 is not involved in termination of IL-6 mediated signal transduction, which appears to be more pronouncedly regulated by the feedback inhibitor SOCS3 (Schmitz et al., 2000) and the tyrosine phosphatase SHP-2 (Lehmann et al., 2003) . Conflicting results exist on whether the activation of certain pathways requires endocytosis as discussed below.
Initial evidence for ligand-induced internalization of IL-6 and its receptors came from studies performed with NIH/3T3 fibroblasts stably transfected with the human IL-6Rα cDNA. Upon stimulation these cells internalized and degraded bound 125I-rhIL-6, although quite inefficiently, which was probably due to limited availability of gp130 (Rose-John et al., 1991) . In contrast, liver cells (HepG2) which naturally express the IL-6Rα internalized the entire bound radiolabeled 125I-rhIL-6 within 60 min (Zohlnhofer et al., 1992) . Similarly, stimulation of COS-7 cells co-expressing IL-6Rα and gp130 with IL-6 resulted in a very rapid intracellular accumulation of 125I-rhIL-6. After 2 h approx. 80% of the initially bound IL-6 was endocytosed (Dittrich et al., 1994) . It was shown, that the endocytic process reduced the amount of IL-6 binding sites at the cell surface. The majority of IL-6, IL-6Rα and gp130 appears to be degraded upon internalization. Full recovery of IL-6 binding sites at the plasma membrane of HepG2 cells required almost 24 h and was dependent on de novo biosynthesis of IL-6Rα. Consequently, the possibility of receptor recycling was precluded. These findings define a classical ligand-induced down-regulation of the IL-6 receptor complex which may play a crucial role in protecting the organism against overstimulation (Zohlnhofer et al., 1992) .
Deletion of the IL-6Rα intracellular region did not affect IL-6 internalization (Dittrich et al., 1994; Graeve et al., 1996) . In sharp contrast, when the entire intracellular region of gp130 was deleted, internalization of IL-6 was completely abrogated (Dittrich et al., 1994) . This indicated that either gp130-dependent signaling or the recruitment of specific adapter proteins was involved in the endocytosis process. Using chimeric receptor constructs, it was shown that abrogation of JAK recruitment to gp130 did not affect stimulus-dependent internalization of gp130. From these experiments, the authors concluded that the initiation of signal transduction is not a prerequisite for endocytosis (Thiel et al., 1998a) . Detailed mutagenesis studies identified a di-leucine motif (L786, L787 in human gp130) as essential and sufficient to mediate uptake of radiolabeled 125I-rhIL6 into transfected cells. Already at this time point, the contribution of N-terminally localized serine residues (S780/S782) to the internalization process was suggested (see next chapter). Therefore, the motif in gp130 (SESTQPLL) resembles formerly identified di-leucine based internalization motifs like pSQIKRLL in CD4 or more generally (D/E)XXXL(L/I/M), to which the adapter protein-2 (AP-2) can bind. This protein complex plays a fundamental role in recruiting cargo proteins into clathrin-coated pits (McMahon and Boucrot, 2011) . Indeed, AP-2 was found to interact with gp130 (Thiel et al., 1998b) . The ligand-imparted endocytosis of the IL-6/IL-6Rα/gp130 complex might therefore be mediated via clathrin-coated vesicles even though final proof is still missing (Thiel et al., 1998b; Tanaka et al., 2008) ( Figure 1B) .
As many di-leucine motif containing receptors traffic to the lysosome for degradation, a similar fate was postulated for gp130. Fusion of a peptide encompassing the identified gp130 di-leucine motif to the IL-2Rα chain resulted in stimulation-dependent internalization, endosomal and lysosomal localization of the fusion protein . Many years later, Tanaka et al. found that IL-6 stimulation induced a lysosome-dependent degradation of gp130, which correlated with an increase in K63-linked polyubiquitination of the protein (Tanaka et al., 2008) .
The E3 ubiquitin ligase cellular homolog of viral Casitas B-lineage lymphoma (c-Cbl) was shown to be recruited to the activated gp130 via binding to the via binding to the SH2-domain containing tyrosine phosphatase (SHP-2). Endosomal sorting and lysosomal degradation of gp130, but not internalization itself, relied on the presence of the vesicular sorting protein hepatocyte growth factor receptor tyrosine kinase substrate (Hrs) (Tanaka et al., 2008) . The exact function and general validity of the K63-linked ubiquitination in the gp130 endocytosis and degradation process remain to be determined.
So far, it remains unclear to what extent gp130 endocytosis contributes to IL-6 signaling strength and quality in vivo. From the gp130 mutant proteins published in a number of studies, conflicting data are available. Murakami et al. showed that the membrane-proximal 61 amino acids of gp130 lacking the di-leucine internalization motif were sufficient to mediate an IL-6-dependent growth response in stably transfected Ba/F3 cells (Murakami et al., 1991) . However, Schaeffer et al. clearly showed that deletion of the aa 771 to 811 (comprising the di-leucine motif) resulted in reduced gp130-mediated proliferation in the same cell type (Schaeffer et al., 2001 ). Furthermore, analysis of a knock-in mouse line expressing a truncated version of gp130 devoid of the di-leucine motif (stop at valine 769), showed that IL-6 mediated ERK1/2 activation was intact (Ernst et al., 2001) . Again, in the study of Schaeffer et al. the gp130 deletion mutant lacking aa 771-811 was unable to activate ERK1/2 (Schaeffer et al., 2001) . Therefore, no clear-cut conclusion can be drawn from the data available so far, with the exception that for activation of the JAK/STAT pathway the internalization of gp130 is not a prerequisite. A fact complicating these analyses was the discovery, that the amino acid sequence comprising the di-leucine endocytosis motif also functions as binding site for the Src kinase hematopoietic cell kinase (Hck) to gp130 (Schaeffer et al., 2001 ). Activation of this kinase appears to be important for the IL-6-dependent proliferation of multiple myeloma cells (Hausherr et al., 2007) . It remains unclear, whether Hck and AP-2 complexes compete for binding to the same recruitment site in gp130 and whether initiation of the proliferative response and endocytosis might be competing cellular events in certain cell types. Interestingly, the crystal structure of the serine-phosphorylated di-leucine motif of CD4, which is most closely related to the gp130 motif, bound to AP-2 did not explain the necessity of the serine modification (Kelly et al., 2008) . Later studies implied that this phosphorylation might allow CD4 entry into endocytic vesicles by disrupting its interaction with the Src family kinase p56(lck) (lymphocyte-specific kinase) (Laguette et al., 
Cross-talk mediated endocytosis of gp130 and its potential pathophysiological role
Gp130 endocytosis can be mediated in trans by pro-inflammatory cytokines and cell stress (Radtke et al., 2010) . Stimulation of different cell types with activators of the p38 MAPK pathway (TNF, IL-1β, UV light, oxidative stress) led to phosphorylation of gp130 on S782 N-terminal to the di-leucine motif. This phosphorylation was dependent on activation of the p38 MAPK substrate mitogen-activated protein kinase activated protein kinase-2 (MK-2), another serine/threonine kinase located in the cytoplasm ( Figure  1A ). Phosphorylation of the serine residue as well as the presence of the di-leucine motif was necessary to allow accelerated uptake of gp130 into early endosomes and subsequent degradation in lysosomes in response to cellular stress (Radtke et al., 2010 ) ( Figure 1A ). This indicated that the presence of gp130 on the cell surface might be post-translationally regulated during inflammatory situations. Indeed, the cell surface levels of gp130 were reduced in monocytes obtained from the synovial fluid of patients with juvenile idiopathic arthritis (JIA) compared to peripheral blood monocytes. Peripheral blood monocytes obtained from healthy donors displayed an equivalent reduction in gp130 surface expression when exposed to synovial fluid of JIA patients. This reduction was dependent on the activation of the p38 MAPK and significantly reduced the responsiveness of the monocytes to IL-6 (Honke et al., 2014) . Furthermore, these results indicated that during cellular stress (e.g. overexpression of proteins, transfection or biosynthesis blockade) the subsequent activation of p38 MAPK might induce a serine phosphorylation of gp130 which could explain and question results indicating a constitutive internalization of gp130 observed in cell culture experiments (Thiel et al., 1998a) . S782 has also been shown to be phosphorylated in response to LIF in a Ca(2+)/calmodulin-dependent protein kinase II (CaMKII)-dependent fashion and was required for LIF-mediated internalization of gp130 (Gibson et al., 2000) . Stimulation of HepG2 cells with IL-6 did not induce S782 phosphorylation (Radtke et al., 2010) , which illustrates that phosphorylation of this residue might be tightly regulated in a cell type-and stimulusdependent fashion. Interestingly, many further studies imply that the expression levels of gp130 are not only modified on the transcriptional level, but also on the post-translational protein level. However, the molecular mechanisms underlying these observations are largely unknown. As example, in biopsies from patients with congestive heart failure, gp130 protein abundance was significantly diminished, despite the fact that its gene expression was increased. The authors concluded that gp130 receptor downregulation balances enhanced cardiotrophin-1 expression in human heart failure and thereby inhibits excessive activation of the gp130 signaling pathway (Zolk et al., 2002) . Other examples can be found in the differentiation process of CD4 + T lymphocytes. Unlike their resting splenic counterparts, Foxp3 + Treg cells from the inflamed central nervous system (CNS-Treg cells) resisted conversion to Th17 cells when exposed to IL-6. Interestingly, this highly activated phenotype of CNS-Tregs displayed a reduced expression of the IL-6Rα and gp130 compared to resting Tregs (O'Connor et al., 2012) .
Another tempting speculation would be that an altered gp130 cell surface expression could switch the responsiveness from one IL-6-type cytokine to another. Initial experiments into this direction were carried out by modulating gp130 protein levels using a tetracyclineregulated expression system in a stromal/osteoblastic cell line, UAMS-32 (O'Brien et al., 2000) . Removal of doxycycline from the culture medium elevated gp130 expression and increased the responsiveness of a STATresponsive promoter-luciferase construct to IL-6/sIL-6Rα, but diminished the responsiveness to its close relative oncostatin M (OSM). This could imply that a change in ratio between gp130 and the OSMR determines whether the cells would be more responsive to IL-6 or OSM. Similar mechanisms might also apply for other cellular systems, which are generally responsive to various IL-6 family cytokines.
Interleukin-1 Receptors and signaling
Interleukin-1 (IL-1) is a master regulator of innate immune responses and stimulates pro-inflammatory processes in multiple ways (Dinarello, 2009 (Dinarello, , 2011 . It acts at very low concentrations although the receptors are not highly expressed on most IL-1 responsive cells ( Matsushima et al., 1986; Uhl et al., 1989) . The two agonists IL-1α and IL-1β as well as the antagonist IL-1Ra are recognized by two different receptors that are part of the Ig superfamily, the IL-1 receptor type I (IL-1RI) (Sims et al., 1988 ) and the IL-1 receptor type II (IL-1RII) (Slack et al., 1993) . The 80 kDa IL-1RI is expressed on almost all cell types, primarily on T cells, fibroblasts and endothelial cells, whereas the 68 kDa IL-1RII is mainly found on neutrophils, monocytes and B cells (Sims and Dower, 1994 ). An intracellular region of 50 aa between residues 477-527 of the IL-1RI known as TIR domain has been shown to be critical for signal transduction (Heguy et al., 1991) . IL-1RII does not trigger the signaling cascade and acts as a decoy receptor to bind IL-1 with high affinity and neutralize its normal cellular effects (Colotta et al., 1993) . Binding of IL-1 to IL-1RI is insufficient for signal transduction. The recruitment of a second receptor subunit is required known as the IL-1R accessory protein (IL-1RAcP). The 66 kDa protein likewise is a member of the Ig superfamily and shows limited homology to IL-1RI and IL-1RII. It does not interact with the ligand directly, but enhances the affinity of the receptor five-fold (Greenfeder et al., 1995) . Upon binding of IL-1α or IL-1β, IL-1RI undergoes conformational changes and forms a heterodimer with IL-1RAcP. The signal transduction of IL-1 has been reviewed recently (O'Neill, 2008) . Briefly, via the IL-1RI and IL-1RAcP TIR domains the signalosome consisting of MyD88, IRAK1, IRAK4, TRAF6 and transforming growth factor beta-activated kinase 1 (TAK1) is built up. The subsequent activation of the IκB kinase (IκK) complex phosphorylates IκBα, leading to its ubiquitination and proteasomal degradation, allowing nuclear factor-kappa B (NF-κB) to translocate into the nucleus. The TAK1 complex also activates MAPK pathways, leading to the activation of p38 MAPK and JNKs. Further excellent reviews have been published recently summarizing the IL-1/IL-1R biosynthesis and processing as well as the physiological and pathophysiological role of IL-1 (Dinarello, 2009; Sims and Smith, 2010; Dinarello, 2011; Garlanda et al., 2013; Netea et al., 2015) . The mechanisms and importance of IL-1 receptor endocytosis will be discussed in the following section.
Ligand-dependent endocytosis of the IL-1 receptor complex
Initial experiments carried out in the T cell lymphoma line EL-4 and fibroblasts demonstrated that in the absence of IL-1 the IL-1R displays a slow turnover rate of 5-11 h. Upon stimulation with IL-1, the receptor is rapidly internalized with a half-life of 60-120 min, but not degraded for up to 4 h (Lowenthal and MacDonald, 1986; Mizel et al., 1987; Horuk and McCubrey, 1989; Curtis et al., 1990) . IL-1α as well as IL-1β, but apparently not IL-1Ra, induce internalization of both IL-1RI and IL-1RII upon binding (Grenfell et al., 1989; Horuk and McCubrey, 1989; Dripps et al., 1991; Bourke et al., 2003) . A series of deletion mutants clarified that the intracellular domain of the IL-1RI is required for IL-1-mediated signaling, but dispensable for ligand binding and internalization of the receptor complex (Heguy et al., 1991) . However, in the absence of IL-1RAcP the IL-1RI failed to induce internalization of radiolabeled 125I-IL-1 which proved that the accessory protein is necessary for IL-1 mediated endocytosis via IL-1RI (Korherr et al., 1997) and presumably IL-1RII. Endocytosis of the IL-1RI is mediated in a clathrin-and dynamin-dependent manner as it can be inhibited by Pitstop2, Dynasore and siRNA-mediated knock-down of dynamin 1 and 2 (Hansen et al., 2013; Windheim and Hansen, 2014) (Figure 2B ). More recent studies identified a role for the intracellular region of the IL-1RI in intracellular trafficking once the receptor complex has been internalized. Brissoni et al. demonstrated that the IL-1RI is ubiquitinated in response to IL-1, which is recognized by the ubiquitin receptor Tollinteracting protein (Tollip). Binding of Tollip to the IL-1RI is required for sorting from late endosomes to lysosomes and the subsequent degradation of IL-1RI (Brissoni et al., (A) IL-1RII/IL-1RAcP endocytosis. Stimulation with IL-1 results in formation of a heterodimeric receptor complex consisting of the decoy receptor IL-1RII and IL-1RAcP. The receptor complex is internalized in a clathrin-dependent fashion, however, neither the internalization motif nor the required adapter proteins have been identified yet. After endocytosis, the IL-1RII appears to recycle to the plasma membrane instead of being degraded. (B) IL-1RI/IL-1RAcP endocytosis. Upon stimulation with IL-1 and formation of the heterodimeric IL-1RI/IL-1RAcP signaling complex, MyD88 is recruited to the receptor complex via TIR/TIR (gray box) interactions. MyD88 is required for the initiation of endocytosis; however, the exact molecular mechanism is unclear to date. The IL-1RI becomes ubiquitinated and recruits Tollip and Tom1 to late endosomes, which are required for the progression to lysosomal degradation.
2006). A model was suggested by which IL-1RI is shuttled from Tollip to target of Myb1 (Tom1), an ubiquitin-and clathrin-binding protein, which in turn recruits components of the degradation machinery such as the sorting protein Hrs (Figure 2B ). Interestingly, Tollip-deficient mice produced less TNF and IL-6 in response to IL-1β, despite the absence of obvious defects in JNK, p38, ERK1/2 phosphorylation or IκBα degradation (Didierlaurent et al., 2006) . This suggests a role for Tollip in the interplay between endocytosis and signaling which regulates the magnitude of the IL-1 response, but which is currently not understood.
Whether the IL-1RII can internalize in the absence of IL-1RAcP has not been addressed so far, but appears unlikely due to the short intracellular region of this receptor. When analyzing human neutrophils the internalization of the IL-1RII was shown to require ATP synthesis and was mediated via clathrin-coated pits (Figure 2A) . Interestingly, removal of the ligand resulted in a rapid re-expression of the decoy receptor and this process was not inhibited by cycloheximide indicating that the IL-1RII is most likely recycled (Bourke et al., 2003) (Figure 2A ). For different transmembrane proteins, including the IL-6 receptor gp130, the TNFR1 and the TNFR2, tyrosine-or di-leucine-based sequences were found to be important for efficient internalization (Trowbridge et al., 1993; Dittrich et al., 1996; Schneider-Brachert et al., 2004; Fischer et al., 2011) . The cytoplasmic domain of IL-1RAcP contains one putative tyrosine-and three di-leucine-based motifs, however, so far no studies directly addressing the identification of endocytosis motifs in the IL-1RAcP have been published.
Importance of IL-1R endocytosis for IL-1-mediated signaling
Even though ligand-induced internalization of the IL-1R complex has been discovered 30 years ago, its importance for IL-1-mediated signaling is still not entirely understood. Inhibition of IL-1 receptor internalization by pharmacological inhibitors resulted in a significantly prolonged phosphorylation of p38 and JNK1/2 and an altered NF-κB-dependent gene expression in response to IL-1 stimulation. Intriguingly, IκBα degradation, nuclear translocation and DNA binding of NF-κB were unaffected, implying a modulating, endosomal compartment-derived signal that remained elusive (Hansen et al., 2013) . Recently, the same group showed that inhibition of IL-1RI internalization blocked IL-1-induced activation of the small GTPase Rac1 and that depletion of Rac1 reduced IL-1-dependent gene expression (Windheim and Hansen, 2014) . Analysis of enriched endomembrane fractions upon stimulation of MCF-7 cells with IL-1β clearly demonstrated that IL-1RI internalization was MyD88-dependent. A signalosome containing the IL-1RI, MyD88, TRAF6, Rac1 and the NADPH oxidase (Nox2) was found in endosomes upon stimulation. The recruitment of TRAF6 to the IL-1RI and the subsequent activation of the IKK complex was shown to be dependent on Nox2-derived generation of reactive oxygen species (Li et al., 2006) .
One interesting aspect for which, however, a putative contribution to the IL-1-mediated receptor endocytosis has not been addressed is the recruitment of β-arrestin to the IL-1R/TRAF6 complex. It was shown that binding of β-arrestin to TRAF6 prevents its autoubiquitination/ oligomerization and therefore subsequently reduces IL-1 stimulated NF-κB activation (Wang et al., 2006) . Notwithstanding, β-arrestins play a crucial role in desensitization and endocytosis of many receptors (reviewed in Kovacs et al., 2009) .
These studies clearly show that ligand-induced internalization of the IL-1 receptor complex is not just a mechanism to deplete IL-1 from the inflammatory site and shut off IL-1-mediated signaling, but that it is critically involved in IL-1-induced gene expression. However, many questions remain to be addressed in future (see conclusions).
Tumor necrosis factor (TNF)
Receptors and signaling TNF is a critical pro-inflammatory cytokine, which has profound functions in immune homeostasis and in host defense against different pathogens (bacteria, viruses, parasites). Uncontrolled TNF signaling has been recognized as a crucial factor involved in many autoimmune diseases and cancer-associated inflammation, which fostered the successful development of anti-TNF biologicals as pharmacological intervention strategies (Taylor and Feldmann, 2009; Danese et al., 2015) . Intriguingly, TNF stimulation can result in the activation of inflammatory and cell survival pathways, but also in the induction of cell death via apoptosis or necroptosis. These apparently divergent signaling outcomes are regulated by the activation of different receptors, formation of different signaling complexes and by spatial separation of the different signalosomes. Excellent reviews have been published regarding TNF-mediated signal transduction (Aggarwal, 2003; Wajant et al., 2003; Van Herreweghe et al., 2010; Wajant and Scheurich, 2011; Walczak, 2011) , the composition and biosynthesis of TNFR1 and TNFR2 receptor complexes (Faustman and Davis, 2013; Puimege et al., 2014) and signal compartmentalization (Schutze et al., 2008) . As before for IL-6 and IL-1, this chapter therefore summarizes reports, which highlight the molecular mechanisms and importance of TNFR endocytosis for the TNF-mediated signaling outcome.
Briefly, TNF signals as a soluble or membrane-bound trimer via the trimeric TNFR1 (CD120a, p55/p60) or the TNFR2 (CD120b, p75/p80) receptor complex. Whereas the TNFR1 is ubiquitously expressed, even though at low levels, the TNFR2 is primarily found on cells of hematopoietic origin, on endothelial cells and cells of the central nervous system. The TNFR1 can be activated very efficiently by soluble (sTNF) as well as membrane-bound TNF (mTNF), while the TNFR2 displays biological responsiveness only to mTNF even though it binds sTNF with high affinity (Grell et al., 1995) . More recent mechanistic studies identified the extracellular membrane-proximal stalk region of the TNFR2 as important region to prevent efficient activation by sTNF (Richter et al., 2012) . The TNFR1 and TNFR2 share substantial homo logy in their extracellular domains (25%), however, their intracellular regions are very distinct. Most prominently, the TNFR2 lacks the death domain present in many other receptors of the TNFR superfamily including TNFR1.
Ligand-dependent endocytosis of the TNF receptor complex
Regarding the TNFR1, it is meanwhile well established that this receptor induces the formation of two signalosomes: the signaling complex-I (also called TNFR signaling complex, TNF-RSC) is comprised of TNFRassociated protein with a death domain (TRADD), RIP1, TRAF2/5, cIAP (cellular inhibitors of apoptosis proteins) ( Figure 3B ) and mediates activation of the NF-κB and MAPK pathways. The complex-II (also called death inducing signaling complex, DISC) contains TRADD, FADD (Fasassociated death domain), procaspase-8 ( Figure 3B ) and is responsible for induction of apoptotic signaling cascades. While it is accepted that the complex-I forms immediately after TNF stimulation at the plasma membrane, conflicting data exist regarding the formation of complex-II ( Figure 3B ). The initial model proposed by Micheau and Tschopp (2003) as well as findings by Harper et al. (2003) and Jones et al. (1999) suggested a dissociation of the complex-I from the TNFR1 and a TNFR1-independent activation of the complex-II in the cytosol.
However, a number of studies carried out by the group of Stefan Schütze demonstrated that after recruitment of TRADD, RIP1 and TRAF2 to TNFR1 at the cell surface, the receptor is internalized and subsequent complex-II formation can occur in association with the TNFR1 at endosomal vesicles (Schneider-Brachert et al., 2004 . Recruitment of the complex-II to the TNFR1 occurred within 3 min after TNF stimulation and remained associated with the TNFR1 for at least 60 min. The motif required for TNF-mediated endocytosis of the TNFR1 was located within the cytoplasmic membraneproximal ten amino acids [aa205-214, TNFR internalization domain (TRID)] and identified by site-directed mutagenesis as the YQRW motif immediately distal to the transmembrane region (Schneider-Brachert et al., 2004) (Figure 3B ). Using a number of different techniques it was shown that abrogation of TNFR1 endocytosis blocked complex-II formation and apoptosis, but still allowed TNF-mediated binding of complex-I (RIP1, TRAF2) and activation of NF-κB (Schutze et al., 1999; Schneider-Brachert et al., 2004 . Interestingly, the adenoviral protein E3-14.7K has been shown to block TNFR1 endocytosis, thereby the recruitment of the complex-II and subsequently TNF-mediated apoptosis (Schneider-Brachert et al., 2006) , while maintaining the NF-κB signaling pathway. This process was independent of the binding of E3-14.7K to optineurin, a protein known to be recruited to 14.7K and involved in vesicular transport (Klingseisen et al., 2012) . Furthermore, the E13 proteins 10.4K and 14.5K which form a complex termed receptor internalization and degradation complex (RID) negatively regulate TNF-mediated NF-κB activation and chemokine synthesis. The RID complex has been shown to directly bind to the TNFR1 complex at the plasma membrane. Downregulation is apparently not due to an increase in the endocytosis rate, but alteration of the intracellular fate of the TNFR1 leading to an accelerated degradation via the lysosomal compartment (Fessler et al., 2004; Chin and Horwitz, 2006) .
A major question that was only recently addressed is how the initiation of endocytosis is regulated and which molecular mechanisms contribute to the switch between the anti-apoptotic, inflammatory cell surface signalosome and the pro-apoptotic endosomal signalosome. Here, a very prominent post-translational modification comes into play: stimulation-dependent ubiquitination. Extensive studies carried out within the last 5 years have highlighted that TNF utilizes an elaborated system of ubiquitin linkages (M1-, K11-, K48-and K63-linked ubiquitin) to recruit, activate or shut off different signaling pathways [reviewed in (Bianchi and Meier, 2009; Walczak, 2011; Walczak et al., 2012) ]. Intriguingly, all four types of ubiquitin linkages can be present simultaneously within one species of a signaling component as exemplified by mass spectrometric analysis of RIP1 (Gerlach et al., 2011) . Ubiquitination of the TNFR1 itself and its contribution to degradation was initially described by Legler et al. (2003) . But it was not until 2014, that Fritsch et al. identified the E3 ubiquitin ligase RNF8-mediated K63-linked ubiquitination of the TNFR1 as crucial for internalization and recruitment of the complex-II (FADD, caspase-8, caspase-7) to allow the propagation of pro-apoptotic signaling of TNFR1 (Fritsch et al., 2014) (Figure 3B ).
Endocytosis of TNFR1 is mandatory for apoptosis induction. Upon localization of the TNFR1 in the endolysosomal compartment, the complex-II composed of FADD and caspase-8 and later on caspase-7 is recruited. This in turn induces acid sphingomyelinase activity, which activates cathepsin D to cleave the BH3 domain-only death agonist protein (BID) and thereby triggers the mitochondrial amplification loop to allow full-blown apoptosis (Schutze et al., 1999; Schneider-Brachert et al., 2004; Edelmann et al., 2011) . Alteration of the acyl chain composition of sphingolipids in ceramide synthase 2 (CerS2) deficient mice inhibited TNFR1 internalization and consequently selectively the pro-apoptotic TNF response (Ali et al., 2013) . The TNFR2 was initially described to be rather shed than internalized upon TNF stimulation of responsive cells (Higuchi and Aggarwal, 1994) . After many years in which endocytosis of TNFR2 remained unaddressed, recent studies show that a di-leucine motif (EQQHLL) located within domain II and a stretch of amino acids located in domain III (aa338-355) are required for clathrin-mediated TNFR2 internalization (Fischer et al., is formed while the receptor is located at the plasma membrane. The TRID region, comprising a tyrosine-based motif, is essential for TNFR1 endocytosis. Furthermore, the receptor becomes K63-ubiquitinated. The exact molecular mechanism of endocytosis is unclear. In the endosomal compartment, the complex-II (TRADD, FADD, caspase 8) is recruited to the TNFR1. It is unclear, whether the complex-II remains bound to the TNFR1 complex or exists mainly in soluble form in the cytoplasm.
2011; Ji et al., 2012 ) ( Figure 3A ). Upon internalization, the TNFR2 localizes to Rab7 positive endosomes/lysosomes and enters the lysosomal degradation pathway. Similar to the TNFR1, abrogation of TNFR2 internalization by point mutation of the di-leucine motif had no influence on the TNFR2-mediated NF-κB activation (Fischer et al., 2011; Ji et al., 2012) ; however, it did inhibit the TNFR2-mediated JNK activation. JNK activity itself was not required for TNFR2 endocytosis (Ji et al., 2012) . Since TNFR2 endocytosis and degradation leads to a subsequent depletion of TRAF2, this process might cross-talk with the TNFR1 and accelerate TNFR1-mediated pro-apoptotic signaling (Fotin-Mleczek et al., 2002) .
Cross-talk mediated endocytosis of the TNF receptor complexes
Interestingly, cross-talk mediated endocytosis has also been demonstrated for the TNFR1 and TNFR2. FotinMleczek et al. showed that cationic cell-penetrating peptides like the Antennapedia homeodomain-derived peptide and Tat-derived peptide as well as the full HIV-1 Tat protein strongly reduce the cell surface localization of both TNFRs. The peptides induce a dynamin-dependent, clathrin-coated vesicle-mediated internalization of the TNFRs without activation of the receptor (FotinMleczek et al., 2005) . Furthermore, low-density lipoprotein receptor-related protein (LRP-1) appears to be able to influence TNFR1 endocytosis in inflammatory situations since LRP-1 deficient murine embryonic fibroblasts display an enhanced TNFR1 cell surface localization with only a minor effect on the total amount of TNFR1 protein. This mechanism might contribute to an LRP-1 mediated suppression of local inflammation observed in atherosclerosis or peripheral nerve injury (Gaultier et al., 2008) . Taken together, endocytosis appears to be a fundamental component of TNF-mediated signaling which helps to compartmentalize its cellular responses, but also for this cytokine the molecular mechanisms are not fully understood.
Conclusions
Even though the process of endocytosis has been recognized to be involved in uptake and degradation of proinflammatory cytokines already more than 25 years ago, the complete momentousness of this cellular process for the regulation of signaling strength and particularly signaling quality has only recently been appreciated. The molecular mechanisms involved in the cytokine receptor recognition, the exact routes of the endocytic process, the signalosomes attached to the cytokine receptors at different intracellular compartments and the ultimate fate of the receptors, however, remain difficult to catch. One reason for this is the rather limited expression level of these cytokine receptors. Therefore, overexpression of the proteins is mostly required for detailed analysis, which might jeopardize the natural trafficking route of the proteins. Methods that are more sophisticated need to be used to address open questions like: What are the adapter proteins and signals required for ligand-dependent endocytosis of the IL-6/IL-6Rα/gp130 complex? What is the in vivo relevance of cross-talk mediated endocytosis of gp130? What is the relevance of serine 782 phosphorylation? Is gp130 trafficking cell-type dependent? What are the internalization motifs and adapter proteins required for endocytosis of the IL-1RI/IL-1RAcP and IL-1RII/IL-1RAcP complex? Which adapter proteins mediate the internalization of the TNFRs? Does cross-talk mediated endocytosis exist for IL-1Rs and TNFRs and if so, what is its physiological relevance? In this respect, the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR associated protein 9) system would offer an innovative technique to delete the expression of suspected proteins and enzymes involved in the endocytosis process or to generate either cell lines or even transgenic mice with knock-in mutants of identified proteins. So far, this technique has not been used to address the in vivo role of pro-inflammatory cytokine receptor endocytosis and its potential involvement in disease development.
